Skip to main content

Cervical Malignancy

Linha Mazin Mohammed, MD Reviewed 06/2022
 


BASICS

DESCRIPTION

  • Cervical cancer is a malignant neoplasm arising from the uterine cervix.

  • Most cervical cancers begin in the transformation zone.

  • 60–75% are from squamous epithelium, and 25–40% are gla...

DIAGNOSIS

HISTORY

  • Patients with HPV infection may be asymptomatic. Early stages can be discovered incidentally as a result of cervical cancer screening.

  • The most common symptoms of cervical cancer are i...

TREATMENT

GENERAL MEASURES

  • Improve nutritional state, correct anemia (Hb <12 g/dL), and treat pelvic infections.

  • Lymph node evaluation is key to staging and treatment

  • Correction of urinary tract obstr...

ONGOING CARE

FOLLOW-UP RECOMMENDATIONS

Patient Monitoring

  • With completion of definitive therapy and based on individual risk factors, patients are evaluated with physical/pelvic examinations:

    • Every 3 to ...

REFERENCES

1
Curry SJ, Krist AH, Owens DK, et al. Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. US Preventive Services Task Force. JAMA. 2018;320:674–86. 
2
C...

ADDITIONAL READING

  • Jin YM, Liu SS, Chen J, et al. Robotic radical hysterectomy is superior to laparoscopic radical hysterectomy and open radical hysterectomy in the treatment of cervical ca...

SEE ALSO

  • Abnormal Pap and Cervical Dysplasia

CODES

ICD10

  • C53.9 Malignant neoplasm of cervix uteri, unspecified

  • C53.0 Malignant neoplasm of endocervix

  • C53.1 Malignant neoplasm of exocervix

  • C53.8 Malignant neoplasm of overlapping sites of cervix uteri

SNOMED

CLINICAL PEARLS

  • Cervical cancer is the second most common malignancy in women worldwide. Improving access to screening is likely to have the greatest impact in the reduction of the burden of disease.

  • W...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

 
×